-
Evaluating Neoadjuvant and Adjuvant Therapies and Benefits for MIBC
13 Jun 2025 20:13 GMT
Matthew Galsky, MD
Professor of Medicine
Director of Genitourinary Medical Oncology
Codirector of the Center of Excellence for Bladder Cancer
Associate Director for Translational Research
Tisch Cancer Center of Mount Sinai
New York, NY
CASE SUMMARY
A 74- …
-
AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans
13 Jun 2025 19:00 GMT
… brief rundown of news involving AstraZeneca and Third Harmonic Bio, as … that you may have missed.
AstraZeneca on Friday formed a new … a 2024 deal that handed AstraZeneca an oral, lipid-lowering therapy … margin, that the drug’s benefits didn’t outweigh the risks …
-
At a bargain-basement valuation now, is AstraZeneca’s share price impossible for me to ignore?
12 Jun 2025 08:24 GMT
… : Getty Images
Pharmaceutical giant AstraZeneca’s (LSE: AZN) share … analysts’ forecasts are that AstraZeneca’s earnings will increase by … to show if a product benefits a specific population. These … principal reason why I kept AstraZeneca – despite only a …
-
AstraZeneca and Pangaea partner for AI detection of hypophosphatasia
10 Jun 2025 08:36 GMT
AstraZeneca’s rare disease business, Alexion, … adults, has the potential to benefit both patients and clinicians by … Alexion Pharmaceuticals became part of AstraZeneca following an acquisition in 2020 …
-
Proteomics Partnerships Move Multiomics from Theory to Practice
13 Jun 2025 22:38 GMT
… partners are Alden Scientific, Amgen, AstraZeneca, Bristol Myers Squibb, Calico Life … sequencing market that would only benefit the scientific community. Ultima’s … the aptamer technology. There are benefits to using oligonucleotides, says Fiona …
-
Frontier IP enters strategic partnership with Abstract Mid-Tech
13 Jun 2025 21:14 GMT
… payment from Abstract and would benefit from a 12-month rent … , home to major institutions including AstraZeneca, GSK, and Addenbrooke’s Hospital … , adding that it expected to benefit from any rental income exceeding …
-
Relacorilant Combo Boosts PFS in Resistant Ovarian Cancer
13 Jun 2025 20:50 GMT
… of response, and clinical benefit rate ([CBR]; all by … ). The PFS and OS benefits with relacorilant were observed across … , respectively. The clinical benefit rates were 51.1% … consulting or advisory role for AstraZeneca, Clovis Oncology, Corcept Therapeutics …
-
Vietnamese PM works with top Swedish firms to foster investment ties
13 Jun 2025 16:24 GMT
… drugs, PM Chính suggested AstraZeneca continue its support for enhancing … “harmonising benefits and sharing risks.”
Emelie Antoni noted that AstraZeneca has operated … facilitate more effective operations for AstraZeneca and other international pharmaceutical …
-
Messenger RNA Market Global and Regional Analysis Report 2025-2035: Advancements in mRNA Technology, Rising Demand for mRNA Vaccines, and Growing Applications in Cancer Therapy Bolster Growth - ResearchAndMarkets.com
13 Jun 2025 15:21 GMT
… the disease. The region also benefits from regulatory advantages and a …
GlaxoSmithKline plc
Arcturus Therapeutics, Inc.
AstraZeneca
Beam Therapeutics Inc.
ModernaTX, Inc …
-
Listed Frontier IP secures deal to create Cambridge innovation hub
13 Jun 2025 11:13 GMT
… , which includes Addenbrookes Hospital, GSK, AstraZeneca, the Babraham Research Campus, Granta … technology companies.
“They stand to benefit from close proximity to Frontier …